mankind1 Posted - 19 hours ago

$LTRN super low volume leakage

jheerdink Posted - 20 hours ago

$LTRN ?

ClownTonioBrown Posted - 20 hours ago

$LTRN reversal?

ClownTonioBrown Posted - 21 hours ago

$LTRN 2.40 at least

ClownTonioBrown Posted - 22 hours ago

$LTRN its nice seeing the bid above 3 dollars again. We can only hope we hit bottom

jheerdink Posted - 1 day ago

$LTRN Panna Sharma, President and CEO of Lantern Pharma. "Japan and other Asian countries have a significantly higher proportion of never-smokers among NSCLC patients, with estimates suggesting that 33-40% of new lung cancer cases in Japan occur in never-smokers. This expansion allows us to accelerate enrollment while addressing a critical unmet need in a region where this disease has a particularly high impact."

CriticalCapital Posted - 1 day ago

$LTRN cool company but gonna wait to load. Might fall to $0.5 based on charts, burn ramp up, and inevitable equity raise. On LT watch

ClownTonioBrown Posted - 1 day ago

$LTRN as much as I want to sell I added a few more shares

ClownTonioBrown Posted - 1 day ago

$LTRN going below 3

jheerdink Posted - 1 day ago

$LTRN "The initiation of patient dosing in Japan is a significant milestone for the HARMONIC™ trial and our mission to develop LP-300 as a potential new treatment option for never-smoker NSCLC patients," said Panna Sharma, President and CEO of Lantern Pharma. $SMMT https://finance.yahoo.com/news/lantern-pharma-announces-first-patient-130000068.html

ClownTonioBrown Posted - 1 day ago

$LTRN hopefully we hit rock bottom

ClownTonioBrown Posted - 1 day ago

$LTRN I’d be shocked if this sticks

jheerdink Posted - 1 day ago

$LTRN Ten clinical trial sites across Japan and Taiwan are actively screening patients, with additional sites expected to also begin patient enrollment in the coming months U.S. clinical sites continue to actively screen and dose patients in both the LP-300 combination arm and the standard-of-care control arm of the Harmonic trial Non-small cell lung cancer (NSCLC) in never smokers occurs at rates 2 to 3 times higher in East Asian countries versus the US and Europe. $MRK https://finance.yahoo.com/news/lantern-pharma-announces-first-patient-130000068.html

Stevelyle2005 Posted - 2 days ago

$LTRN Hold and watch, weak next 6-24 months.

ClownTonioBrown Posted - 2 days ago

$LTRN this is nerve wracking but here we are

ClownTonioBrown Posted - 2 days ago

$CLIR $LTRN good weekend in the Sportsbook

Iman133 Posted - 4 days ago

$CERO $LTRN $LVGO $LWEL $LXRX Blocked

LordThanaton Posted - 4 days ago

$LXRX $LVGO $LTRN $CERO $LWEL at first i thought this was getting spammie too. Upon further investigation, they are changing the tags of each post. Furthering the reach and eyes looking at the ticker. I can't be mad they are spending time and effort increasing the reach of CEROs Phase 1 FDA approved Human trails.

Iman133 Posted - 4 days ago

$CERO $LTRN $LVGO $LWEL $LXRX Blocked

kellyhart1775 Posted - 5 days ago

$LTRN LTRN is a great small cap….just needs to be recognized. Similar companies with their advancements to date have MC’s at multiples much higher. $250M at a minimum.

ClownTonioBrown Posted - 5 days ago

$LTRN bring this down as much as you’d like! Accumulating starts now

ClownTonioBrown Posted - 5 days ago

$LTRN who knows how many years we will be held down for! Paytience

jheerdink Posted - 6 days ago

$LTRN "New data and scientific findings conducted in conjunction with Drs. Yong Du and Shiaw-Yih (Phoebus) Lin at MD Anderson were presented at The Immuno-Oncology Summit 2024. The findings showcased what Lantern believes to be the role of LP-184 to be combined with checkpoint inhibitors to provide greater response in TNBC due to synergy and to potentially transform TNBC tumors that are unresponsive (cold) to checkpoint inhibitors to responsive (hot). The poster was titled: LP-184, a Novel Acylfulvene, Sensitizes Immuno-Refractory Triple Negative Breast Cancers (TNBCs) To Anti-PD1 Therapy by Affecting the Tumor Microenvironment." $MRK https://finance.yahoo.com/news/lantern-pharma-reports-third-quarter-210500755.html

ClownTonioBrown Posted - 6 days ago

$LTRN things are not looking good. This board used to be so alive. I added more so prepare for the dip

ClownTonioBrown Posted - 6 days ago

$LTRN good morning ltrn team!

ClownTonioBrown Posted - 1 week ago

$LTRN all stocks go up and I buy this one

ClownTonioBrown Posted - 1 week ago

$LTRN I think this is everyone’s favorite stock

ClownTonioBrown Posted - 1 week ago

$LTRN is Marty still here?

jheerdink Posted - 1 week ago

$LTRN Non-Smokers Keep Getting Lung Cancer. Dallas’ Lantern Pharma Is Using AI to Fight Back A study found that 57 percent of Asian women diagnosed with lung cancer never smoked. https://www.dmagazine.com/healthcare-business/2024/10/non-smokers-keep-getting-lung-cancer-dallas-lantern-pharma-is-using-ai-to-fight-back/

kellyhart1775 Posted - 1 week ago

$LTRN I am surprised as well. I cannot any reason for it not to be at a multiple considerably higher. Any other company would be at a much much higher market cap. Is it lack of exposure ?